MedPlus Health Services Profit & Loss Annual

BSE: 543427 | NSE: MEDPLUS | ISIN: INE804L01022 | Sector: Retail (Drugs)

662.70 -7.95 (-1.19%)Updated : 10 Sep 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	6,561.95	5,897.27	5,493.57	4,472.10
Other Net	19.30	15.25	13.55	12.99
Diluted Weighted Average Shares	12.01	12.00	12.00	11.97
Gain( Loss)on Saleof Assets	2.71	5.82	4.07	3.85
Depreciation/ Amortization	283.96	250.65	225.40	182.04
Operating Income	330.51	238.79	131.29	85.47
Net Income	219.65	150.32	65.47	49.76
Income Availableto Com Excl Extra Ord	219.65	150.32	65.47	49.76
Other Operating Expenses Total	-2.69	1.61	1.07	0.95
Net Income Before Taxes	275.33	183.29	73.44	47.16
Minority Interest	0.04	0.09	-0.10	-0.34
Net Income After Taxes	219.61	150.23	65.58	50.11
Income Availableto Com Incl Extra Ord	219.65	150.32	65.47	49.76
Costof Revenue Total	5,084.61	4,640.66	4,391.63	3,557.69
Gross Profit	1,807.86	1,495.39	1,233.23	999.89
Interest Inc( Exp) Net- Non- Op Total	-77.19	-76.57	-75.46	-55.15
Diluted Net Income	219.65	150.32	65.47	49.76
Provisionfor Income Taxes	55.72	33.06	7.87	-2.94
period Type	-	-	-	-
Net Income Before Extra Items	219.65	150.32	65.47	49.76
Total Revenue	6,892.47	6,136.05	5,624.86	4,557.58
period Length	12.00	12.00	12.00	12.00
Revenue	6,892.47	6,136.05	5,624.86	4,557.58
Selling/ General/ Admin Expenses Total	1,196.07	1,004.35	875.47	731.43
Diluted Normalized EPS	18.11	12.13	5.15	3.95
Diluted EPS Excluding Extra Ord Items	18.29	12.52	5.45	4.16

*All figures in crores except per share values

272.00+6.05(2.27%)

1,260.00+20.50(1.65%)

11,053.00+157.00(1.44%)

1,196.80-29.75 (-2.43%)

185.95-2.60 (-1.38%)

Related News